Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Abpro Bio Co., Ltd.

Capitalization 74.02B 50.12M 43.24M 39.04M 37.42M 68.01M 4.62B 71.11M 461M 185M 2.21B 188M 184M 7.93B P/E ratio 2023
-5.89x
P/E ratio 2024 -7.86x
Enterprise value 74.41B 50.39M 43.47M 39.25M 37.62M 68.37M 4.64B 71.49M 463M 186M 2.22B 189M 185M 7.97B EV / Sales 2023
5.8x
EV / Sales 2024 4.06x
Free-Float
92.81%
Yield 2023 *
-
Yield 2024 -
25-10-01 Investors left reading tea leaves Zonebourse
25-08-25 Abpro Bio Co., Ltd.(KOSDAQ:A195990) dropped from S&P Global BMI Index CI
24-06-16 Abpro Bio Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
24-06-12 Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
23-05-15 Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
22-12-15 Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim. CI
22-09-25 Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion. CI
21-12-23 Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding CI
21-10-13 Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding CI
21-06-17 Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm CI
21-06-15 Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm CI
20-12-21 KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion. CI
20-12-14 Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd. CI
1 day-7.28%
1 month-22.65%
3 months-51.22%
6 months-33.01%
Current year-46.15%
1 month 1,390
Extreme 1390
1,920
Current year 1,390
Extreme 1390
2,750
1 year 1,390
Extreme 1390
4,470
3 years 1,390
Extreme 1390
9,400
5 years 1,390
Extreme 1390
17,100
10 years 1,390
Extreme 1390
40,500
Manager TitleAgeSince
Chief Executive Officer 64 2024-04-29
Sales & Marketing 56 2014-10-31
Director TitleAgeSince
Director/Board Member 64 2019-08-22
Director/Board Member 58 2020-04-08
Director/Board Member 56 2024-04-29
Change 5d. change 1-year change 3-years change Capi.($)
-7.28%-.--%-57.06%-64.65% 26.99M
+1.50%-4.25%+75.93%+41.00% 2.91B
+2.02%-2.94%+8.58%+28.21% 2.85B
+2.45%-6.56%+17.82%+33.09% 2.26B
+4.31%-12.34%-18.49%+15.62% 2.24B
+4.21%-7.11%+82.88%+303.43% 2.08B
+2.20%-4.46%-16.23%-3.24% 1.95B
+8.21%+8.53%+215.73%+78.66% 1.86B
+4.52%-5.06%+213.67%+233.96% 1.84B
+11.66%-1.63%+127.30%-25.71% 1.83B
Average +3.38%-1.16%+65.01%+64.04% 1.98B
Weighted average by Cap. +4.18%+0.94%+71.06%+73.66%

Financials

2023 2024
Net sales 25.38B 17.18M 14.82M 13.39M 12.83M 23.31M 1.58B 24.38M 158M 63.37M 757M 64.51M 63.12M 2.72B 31.66B 21.44M 18.5M 16.7M 16.01M 29.09M 1.98B 30.42M 197M 79.08M 945M 80.49M 78.76M 3.39B
Net income -25.74B -17.43M -15.04M -13.58M -13.01M -23.65M -1.61B -24.73M -160M -64.29M -768M -65.44M -64.03M -2.76B -15.63B -10.58M -9.13M -8.24M -7.9M -14.36M -975M -15.01M -97.34M -39.03M -466M -39.73M -38.88M -1.67B
Net Debt -8.07B -5.47M -4.72M -4.26M -4.08M -7.42M -504M -7.76M -50.29M -20.17M -241M -20.53M -20.08M -865M 396M 268K 231K 209K 200K 363K 24.68M 380K 2.46M 988K 11.81M 1.01M 984K 42.37M
Logo Abpro Bio Co., Ltd.
Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.
Employees
44
  1. Stock Market
  2. Equities
  3. A195990 Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW